Conference · San Francisco, California
Novel Cardiovascular Therapeutics Summit
Health · Medicine · Science
Key numbers
- Editions on record
- 1first in 2017
About Novel Cardiovascular Therapeutics Summit
Accelerating Cardiovascular Pharmacological Therapy Development, Translational Science & Clinical Research The Novel Cardiovascular Therapeutics Summit reveals how the latest developments in the genetic and molecular understanding of cardiovascular disease, heart failure and cardiomyopathy are being translated into new pharmacological therapies in the clinic. From the state of the art on cardiovascular drug development, to innovative therapeutic approaches, precision medicine and advancements in clinical trial methodologies, this meeting combines cutting edge science with a practical evaluation of case studies. The agenda has been designed with insight from academicians and biopharmaceutical leaders in cardiovascular clinical research to help you tackle your major preclinical and clinical challenges to achieve safer, faster and more cost-effective cardiovascular drug development. This is a great opportunity to interact with fellow peers in frank discussions that will ensure that you leave with the tools and ideas to advance your research and help shape the future of cardiovascular therapies.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 28 Feb – 1 Mar 2017 | Sheraton Fisherman's Wharf Hotel San Francisco, California | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Novel Cardiovascular Therapeutics Summit?
The next dates haven't been confirmed. The last edition we have on record was 28 Feb – 1 Mar 2017.
Where is it held?
The last edition we have was at Sheraton Fisherman's Wharf Hotel, San Francisco, California.